Introduction
There is evidence that persons with schizophrenia are poorly or non-adherent to medications. In subSaharan Africa, the magnitude of poor or non-adherence is huge. [1] [2] [3] [4] [5] Direct comparison of the prevalence and determinants of poor or non-adherence with reports from Europe and North America is limited by differences in methodology and case ascertainment criteria. While some studies utilize non-standardized methods of indirectly ascertaining the magnitude of poor or nonadherence, others utilizing validated measures report conflicting findings. 6 Poor or non-adherence to medication should not be restricted to a dichotomous division between poor or good adherence, but should rather examine the concept as a dimension that would guide appropriate intervention. 7 Unlike other measures of adherence, the Medication Adherence Rating Scale (MARS) describes an individual's medication adherence in three dimensions: medication adherence behavior, attitude toward taking medication, and negative side effects and attitudes to psychotropic medication. 7 Indeed, self-report measures of medication-taking behavior overestimate adherence when compared to objective measures, 8 and this is perhaps why it has been argued that aside from medication-taking behavior, self-report measures should also assess for barriers to adherence and beliefs. 9 The MARS has not been well utilized in sub-Saharan Africa: the authors only identified one previous report. 10 The MARS is a 10-item self-report questionnaire developed after combining the Medication Adherence
Questionnaire and the Drug Attitude Inventory. 11 The developers validated this tool in patients with psychosis and reported good psychometric properties (reliability and validity) in a moderately sized sample. Fialko et al. 12 confirmed the three-dimensional factor structure of the MARS but reported low internal consistency.
The three-dimensional structure was also confirmed in a population of homeless patients with schizophrenia across France. 13 No study has assessed the validity of the MARS in a non-western setting. There is also a need to utilize a brief assessment tool for medication adherence research in schizophrenia in these settings, facilitating the development of specific interventions to improve schizophrenia treatment outcomes. This study therefore aimed to assess the psychometric properties of the MARS in a schizophrenia cohort receiving outpatient care at a regional psychiatric hospital in Nigeria. 
Methodology Setting

Medication Adherence Rating Scale (MARS)
The MARS is a 10-item self-reporting multidimensional instrument describing three dimensions: medication non-adherence. 7, 12 It has also been used in Nigeria.
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Mini International Neuropsychiatric Interview (MINI) English version 5
The MINI is a short structured diagnostic interview developed by Sheehan et al. 14 It is used to diagnose major axis 1 psychiatric disorders based on DSM-IV and ICD-10 criteria. It has good inter-rater and retest reliability. The MINI has been used in studies on schizophrenia in Nigeria. [15] [16] [17] The psychosis module was used to confirm the diagnosis of the patients in the present study.
The Positive and Negative Syndrome Scale (PANSS)
The PANSS was administered to all participants to assess symptom severity. 18 The PANSS has subscales The scale has been found to be a valid and reliable means of measuring symptoms of schizophrenia. The instrument has been used extensively in studies on schizophrenia in Nigeria. 19, 20 
Scale to Assess Unawareness of Mental Disorder (SUMD)
This is a semi-structured interview questionnaire designed to assess insight. The abbreviated version of the SUMD was used in this study. It has a total of 11 domains and 6 items that describe 3 dimensions: The scale assesses insight on each domain on the basis of awareness and attribution of symptoms. This instrument has also been used previously in Nigeria.
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Pilot testing
We pilot-tested the MARS to determine that the questions were easily understood. We decided that the MARS as well as other rating scales would be administered by the researchers to facilitate understanding of each question. We identified that low level of education among some participants would make it difficult for them to read the questions; however, understanding was usually improved if questions were read out loud. A similar method has been employed in Brazil.
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Data analysis
We entered data from paper questionnaires into an electronic spreadsheet (SPSS version 21). We summarized data using descriptive statistics and presented them in tables. Bivariate analyses were conducted using two tailed t-tests, and correlations were conducted using Pearson's correlations following normality testing using Kolmogorov-Smirnov tests.
Confirmatory factor analysis was performed to delineate the factor structure of the MARS in this cohort. Level of significance was set at p<0.05 a priori.
Results
Sociodemographic characteristics
The mean age (standard deviation) of participants was 39.07 (11.42) years. The majority were male (n=129; 56.1%), with most having at least 12 years of formal education (n=140; 60.9%). Over half of the participants were single (n=132; 57.4%) and unemployed (n=140; 60.9%).
Clinical characteristics
Less than half of the participants were currently psychotic when interviewed with the MINI (n=101;
43.9%) and most had not received inpatient care (n=140; 60.9%). The majority was being managed with first-generation antipsychotics (n=144; 62.6%), and just over a quarter on second-generation antipsychotics (n=60; 26.1%); a minority was on a combination of firstand second-generation antipsychotics (n=26; 11.3%).
The routes of medication taking were oral alone (n=125;
54.3%), oral and depot, or long-acting injections (n=101;
43.9%), and depot alone (n=4; 1.7%) ( Table 1) .
MARS scores
The mean (standard deviation) MARS score was 3.92 (2.69). The scores ranged between 0 and 10; the median score was 4, while the interquartile range was between 2 and 6. There were no differences in mean MARS scores across gender (t=0.25, p=0.80)
or whether inpatient care was received after a relapse Responses to the MARS items are shown in Table 2 .
Reliability and factor structure
The reliability of the MARS was tested and a score of 0.76 indicated good internal structure of the items. After one item was removed from the analysis, the scores ranged between 0.72 and 0.77, suggesting minimal or no redundancy of items in the scale. Despite the moderate to good alpha score obtained, the factor structure of the MARS was assessed using a principal component and factor analysis with varimax rotation, with Eigenvalues greater than 1 being retained. A 3-factor solution was produced (Table 3) . Factors 1 to 3 accounted for 28.7, 15.1 and 14.6% of the variance, respectively, at a total of 58.4%. The reliability of the three factors were: factor 1, 0.80; factor 2, 0.50; and factor 3, 0.54. 
Relationship with psychopathology
Total MARS scores had a weak but statistically significant association with the PANSS positive subscale 
Relationship with insight
Total MARS scores showed a weak but statistically significant relationship with awareness of mental illness factor as the most reliable one. 12, 23, 24 Even though this study confirmed a 3-factor structure for the MARS, consistent with some previous reports, other authors have suggested 2-and 5-factor structures based on their analysis. In contrast to the findings of Thompson et al. 7 and Fialko et al., 25 in our study, the first factor from the confirmatory factor analysis comprised 6 items vs. 5 items from previous research. This may have accounted for the improved reliability of this factor in this study, as well as the consistency of this factor in external validity testing.
The additional item, "It is unnatural for my mind and Both questions appear to explore insight towards the illness. We observed that there was a significant but moderate correlation between item 7 on the MARS and the awareness of the need for treatment domain in the SUMD (analysis not shown). The domain on negative side effects of medication showed a high factor loading.
The high loading may result from a preponderance of participants on first-generation antipsychotics, which, though effective, can have notable side effects of bradykinesia and rigidity.
Our findings should be taken into consideration with some limitations in view. First, it would have been ideal to compare subjective rating of adherence with health worker-rated perception of adherence; however, we utilized an "indirect" measure of adherence which was to identify participants on depot preparations, who receive such preparations primarily due to poor or non-adherence. 26 Second, while this study overcomes a limitation identified by Fialko et al. 25 in using an outpatient population exclusively, it may not be entirely 
Conclusion
This study confirms the dimensional structure of the MARS, in line with other studies. It discriminated well between participants on depot preparations compared to those on oral medications. Even though internal consistency was strong, external validity testing showed weak to moderate associations with illness severity and insight. Further research is needed with larger sample sizes and a cohort study design.
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